Temat: "Smoking Cessation" - OpacWWW

Starter badań:

Smoking cessation.

Smoking is addictive —both physically and psychologically. The physical addiction can be traced to the nicotine in each cigarette. It hooks an individual just as completely as heroin and cocaine, and the withdrawal symptoms—cravings, anxiety, agitation, nausea, cramps, depression, and dizziness—are similar.

Salem Press Encyclopedia of Health, 2019. 2p.

Skocz do pozycji: 1 1.

Tytuł :: Transcranial Magnetic Stimulation Treatment for Smoking Cessation: An Introduction for Primary Care Clinicians.
Autorzy :: Young JR; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute (DCRI), Duke University School of Medicine, Durham, NC; Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC), Durham Veterans Affairs Health Care System, NC; Durham Veterans Affairs Health Care System, NC. Electronic address: .
Galla JT; Department of Psychology and Neuroscience, Trinity College of Arts and Sciences, Duke University, Durham, NC.
Appelbaum LG; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Center for Cognitive Neuroscience, Duke University, Durham, NC.; Pokaż więcej
Źródło :: The American journal of medicine [Am J Med] 2021 Nov; Vol. 134 (11), pp. 1339-1343. Date of Electronic Publication: 2021 Aug 15.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms :: Primary Health Care*
Smoking Cessation/*methods
Tobacco Use Disorder/*therapy
Transcranial Magnetic Stimulation/*methods
Humans ; Psychotherapy ; Smoking Cessation Agents/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
Autorzy :: Russo C; Ambulatorio Di Diabetologia, UOC Medicina Interna E D'Urgenza, Policlinico Universitario, AOU 'Policlinico-V. Emanuele', Catania, Italy.
Caponnetto P; Centro Per La Prevenzione E Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria 'Policlinico-V.Emanuele' Dell'Università Di Catania, Via S. Sofia 78, 95123, Catania, Italy.
Cibella F; Institute for Biomedical Research and Innovation, National Research Council of Italy, Palermo, Italy.
Maglia M; Centro Per La Prevenzione E Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria 'Policlinico-V.Emanuele' Dell'Università Di Catania, Via S. Sofia 78, 95123, Catania, Italy.
Alamo A; Centro Diabetologico - UOC Andrologia Ed Endocrinologia, Policlinico Universitario, AOU 'Policlinico-V. Emanuele', Catania, Italy.
Campagna D; Ambulatorio Di Diabetologia, UOC Medicina Interna E D'Urgenza, Policlinico Universitario, AOU 'Policlinico-V. Emanuele', Catania, Italy.; UOC MCAU, University Teaching Hospital 'Policlinico-Vittorio Emanuele', University of Catania, Catania, Italy.
Frittitta L; Centro Per Il Diabete E L'Obesità - UOC Endocrinologia, Ospedale Garibaldi Nesima, ARNAS Garibaldi, Catania, Italy.; Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), Dipartimento Di Medicina Clinica E Sperimentale, Università Di Catania, Catania, Italy.
Di Mauro M; Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), Dipartimento Di Medicina Clinica E Sperimentale, Università Di Catania, Catania, Italy.; Ambulatorio Di Diabetologia, Ospedale V. Emanuele, AOU 'Policlinico-V. Emanuele', Catania, Italy.
Leotta C; Ambulatorio Di Diabetologia - UOC Geriatria, Ospedale Cannizzaro, Catania, Italy.
Mondati E; Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), Dipartimento Di Medicina Clinica E Sperimentale, Università Di Catania, Catania, Italy.; UOS Sorveglianza Delle Complicanze Delle Malattie Metaboliche, Ospedale S. Marta, AOU 'Policlinico-V. Emanuele', Catania, Italy.
Krysiński A; Mossakowski Clinical Research Centre, Polish Academy of Sciences, Warsaw, Poland.; Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital MSWiA, Warsaw, Poland.
Franek E; Mossakowski Clinical Research Centre, Polish Academy of Sciences, Warsaw, Poland.; Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital MSWiA, Warsaw, Poland.
Polosa R; Ambulatorio Di Diabetologia, UOC Medicina Interna E D'Urgenza, Policlinico Universitario, AOU 'Policlinico-V. Emanuele', Catania, Italy. .; Centro Per La Prevenzione E Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria 'Policlinico-V.Emanuele' Dell'Università Di Catania, Via S. Sofia 78, 95123, Catania, Italy. .; Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), Dipartimento Di Medicina Clinica E Sperimentale, Università Di Catania, Catania, Italy. .; Pokaż więcej
Źródło :: Internal and emergency medicine [Intern Emerg Med] 2021 Oct; Vol. 16 (7), pp. 1823-1839. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Smoking Cessation*
Smoking Cessation Agents/*therapeutic use
Tobacco Use Disorder/*drug therapy
Varenicline/*therapeutic use
Adult ; Aged ; Diabetes Mellitus, Type 2 ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.
Autorzy :: Ray LA; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Green R; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Enders C; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Leventhal AM; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Grodin EN; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Li G; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Lim A; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Hartwell E; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Venegas A; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Meredith L; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Nieto SJ; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Shoptaw S; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Ho D; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).
Miotto K; Department of Psychology (Ray, Green, Enders, Grodin, Lim, Hartwell, Venegas, Meredith, Nieto, Ho), Department of Psychiatry and Biobehavioral Sciences (Ray, Miotto), Department of Biostatistics (Li), and Department of Family Medicine (Shoptaw), University of California, Los Angeles; Department of Preventive Medicine, University of Southern California, Los Angeles (Leventhal).; Pokaż więcej
Źródło :: The American journal of psychiatry [Am J Psychiatry] 2021 Sep 01; Vol. 178 (9), pp. 818-828. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Smoking Cessation*
Alcohol Deterrents/*therapeutic use
Alcohol Drinking/*drug therapy
Naltrexone/*therapeutic use
Smoking Cessation Agents/*therapeutic use
Varenicline/*therapeutic use
Adult ; Cholinergic Agonists/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Narcotic Antagonists/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Autorzy :: Chen LS; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, Missouri, USA.
Baker TB; Division of General Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Miller JP; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Bray M; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Smock N; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Chen J; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Stoneking F; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Culverhouse RC; John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.; Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri, USA.
Saccone NL; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, USA.
Amos CI; Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.; Department of Medicine, Baylor College of Medicine, Institute for Clinical and Translational Research, Houston, Texas, USA.
Carney RM; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.
Jorenby DE; Division of General Internal Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Bierut LJ; Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA.; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, Missouri, USA.; Pokaż więcej
Źródło :: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Dec; Vol. 108 (6), pp. 1315-1325. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Pharmacogenomic Variants*
Smokers*
Smoking Cessation*
Tobacco Use Cessation Devices*/adverse effects
Nerve Tissue Proteins/*genetics
Nicotine/*administration & dosage
Nicotinic Agonists/*therapeutic use
Receptors, Nicotinic/*genetics
Smoking Cessation Agents/*therapeutic use
Varenicline/*therapeutic use
Administration, Cutaneous ; Administration, Oral ; Adult ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Missouri ; Nicotine/adverse effects ; Nicotinic Agonists/adverse effects ; Pharmacogenetics ; Prospective Studies ; Race Factors ; Smoking Cessation Agents/adverse effects ; Time Factors ; Treatment Outcome ; Varenicline/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
Autorzy :: Ebbert J; Department of Medicine, Mayo Clinic, Rochester, MN.
Jimenez-Ruiz C; Smoking Cessation Service, Madrid, Spain.
Dutro MP; Medical Affairs, Pfizer Inc, New York, NY.
Fisher M; Medical Affairs, Pfizer Inc, Madison, NJ.
Li J; Biostatistics, Pfizer Inc, Madison, NJ.
Hays JT; Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: .; Pokaż więcej
Źródło :: Mayo Clinic proceedings [Mayo Clin Proc] 2021 Jul; Vol. 96 (7), pp. 1801-1811. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Bupropion*/administration & dosage
Bupropion*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/classification
Drug-Related Side Effects and Adverse Reactions*/diagnosis
Drug-Related Side Effects and Adverse Reactions*/etiology
Smoking Cessation Agents*/administration & dosage
Smoking Cessation Agents*/adverse effects
Varenicline*/administration & dosage
Varenicline*/adverse effects
Smoking/*drug therapy
Smoking Cessation/*methods
Tobacco Use Cessation Devices/*adverse effects
Adult ; Drug Tapering/methods ; Female ; Humans ; Male ; Middle Aged ; Outcome and Process Assessment, Health Care
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Direct patient care services by community and ambulatory care pharmacists in Idaho.
Autorzy :: Nguyen E; Idaho State University College of Pharmacy, Meridian, ID, USA.
Holmes JT; Idaho State University College of Pharmacy, Meridian, ID, USA.
Narsinghani R; Idaho State University College of Pharmacy, Meridian, ID, USA.
O'Connor S; Idaho State University College of Pharmacy, Meridian, ID, USA.
Fuit MW; Idaho State University College of Pharmacy, Meridian, ID, USA.
Thaden L; Idaho State University College of Pharmacy, Meridian, ID, USA.
Robinson R; Idaho State University College of Pharmacy, Meridian, ID, USA. .; University of Alaska Anchorage/Idaho State University, 2533 Providence Drive, PSB 108B, Anchorage, AK, USA. .; Pokaż więcej
Źródło :: International journal of clinical pharmacy [Int J Clin Pharm] 2020 Dec; Vol. 42 (6), pp. 1480-1489. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji :: Journal Article
MeSH Terms :: Ambulatory Care*/economics
Community Pharmacy Services*/economics
Delivery of Health Care*/economics
Pharmacists*/economics
Professional Role*
Smoking Cessation*/economics
Diabetes Mellitus/*therapy
Cross-Sectional Studies ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/economics ; Health Care Surveys ; Humans ; Idaho ; Insurance, Health, Reimbursement ; Insurance, Pharmaceutical Services ; Smoking Cessation Agents ; Tobacco Use Cessation Devices ; Workflow ; Workload
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
Autorzy :: Giulietti F; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Filipponi A; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Rosettani G; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Giordano P; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.
Iacoacci C; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.
Spannella F; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy.; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Sarzani R; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, Pulmonology and Respiratory Medicine Clinic, Centre for Smoking Cessation, IRCCS INRCA, Ancona, Italy. .; Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy. .; Pokaż więcej
Źródło :: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2020 Oct; Vol. 27 (5), pp. 349-362. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Smoking Cessation*
Alkaloids/*therapeutic use
Bupropion/*therapeutic use
Smoking/*adverse effects
Smoking Cessation Agents/*therapeutic use
Tobacco Use Disorder/*drug therapy
Varenicline/*therapeutic use
Alkaloids/adverse effects ; Azocines/adverse effects ; Azocines/therapeutic use ; Bupropion/adverse effects ; Clinical Decision-Making ; Electronic Nicotine Delivery Systems ; Humans ; Quinolizines/adverse effects ; Quinolizines/therapeutic use ; Recurrence ; Risk Factors ; Smoking Cessation Agents/adverse effects ; Tobacco Use Cessation Devices ; Tobacco Use Disorder/diagnosis ; Tobacco Use Disorder/physiopathology ; Tobacco Use Disorder/psychology ; Treatment Outcome ; Varenicline/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Why It Is Difficult for Military Personnel to Quit Smoking: From the Perspective of Compensatory Health Beliefs.
Autorzy :: Au-Yeung CS; Postgraduate Programs in Management, I-Shou University, Kaohsiung 84001, Taiwan.
Chao RF; Department of Leisure Management, I-Shou University, Kaohsiung 84001, Taiwan.
Hsu LY; Postgraduate Programs in Management, I-Shou University, Kaohsiung 84001, Taiwan.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Nov 22; Vol. 18 (22). Date of Electronic Publication: 2021 Nov 22.
Typ publikacji :: Journal Article
MeSH Terms :: Military Personnel*
Smoking Cessation*
Attitude of Health Personnel ; Humans ; Motivation ; Smoking ; Surveys and Questionnaires ; Tobacco Smoking
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder.
Autorzy :: Lum A; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia. Electronic address: .
Skelton E; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
Robinson M; Drug & Alcohol Clinical Services, Hunter New England Local Health District, Newcastle Community Health Centre, 670 Hunter Street, Newcastle West, NSW 2302, Australia.
Guillaumier A; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
Wynne O; Drug & Alcohol Clinical Research & Improvement Network, St Leonards, NSW 2065, Australia.
Gartner C; University of Queensland, Faculty of Medicine, School of Public Health, St Lucia, QLD 4072, Australia.
Borland R; University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, School of Psychological Sciences, Melbourne, VIC 3010, Australia.
Baker A; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
Dunlop A; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia; Drug & Alcohol Clinical Services, Hunter New England Local Health District, Newcastle Community Health Centre, 670 Hunter Street, Newcastle West, NSW 2302, Australia; Drug & Alcohol Clinical Research & Improvement Network, St Leonards, NSW 2065, Australia.
Wilkinson RB; Clinical Research Design & Statistics, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia.
Bonevski B; The University of Newcastle, Faculty of Health and Medicine, School of Medicine and Public Health, 1 University Drive, Callaghan, NSW 2308, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia; Flinders University, College of Medicine & Public Health, Level 5 Flinders Medical Centre, Bedford Park, SA 5042, Australia.; Pokaż więcej
Źródło :: Addictive behaviors [Addict Behav] 2022 Jan; Vol. 124, pp. 107097. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Electronic Nicotine Delivery Systems*
Smoking Cessation*
Substance-Related Disorders*
Australia ; Humans ; Nicotine/therapeutic use ; Tobacco Use Cessation Devices
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Addressing smoking in sheltered homelessness with intensive smoking treatment (ASSIST project): A pilot feasibility study of varenicline, combination nicotine replacement therapy and motivational interviewing.
Autorzy :: Skelton E; The University of Newcastle, College of Health, Medicine, and Wellbeing, 1 University Drive, Callaghan, NSW 2038, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia. Electronic address: .
Lum A; The University of Newcastle, College of Health, Medicine, and Wellbeing, 1 University Drive, Callaghan, NSW 2038, Australia. Electronic address: .
Cooper LE; St Vincent's de Paul Society NSW, Support Services, Matthew Talbot Hostel Clinic, NSW 2001, Australia. Electronic address: .
Barnett E; St Vincent's de Paul Society NSW, Support Services, Matthew Talbot Hostel Clinic, NSW 2001, Australia. Electronic address: .
Smith J; St Vincent's de Paul Society NSW, Support Services, Matthew Talbot Hostel Clinic, NSW 2001, Australia. Electronic address: .
Everson A; St Vincent's de Paul Society NSW, Support Services, Matthew Talbot Hostel Clinic, NSW 2001, Australia. Electronic address: .
Machart J; St Vincent's de Paul Society NSW, Support Services, Matthew Talbot Hostel Clinic, NSW 2001, Australia. Electronic address: .
Baker AL; The University of Newcastle, College of Health, Medicine, and Wellbeing, 1 University Drive, Callaghan, NSW 2038, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia. Electronic address: .
Halpin S; The University of Newcastle, College of Engineering, Science and Environment, School of Psychological Sciences, 1 University Drive, Callaghan, NSW 2038, Australia. Electronic address: .
Nielssen O; Macquarie University, Balaclava Road, Macquarie Park, NSW 2109, Australia. Electronic address: .
Clapham M; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia. Electronic address: .
Bonevski B; The University of Newcastle, College of Health, Medicine, and Wellbeing, 1 University Drive, Callaghan, NSW 2038, Australia; Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia; Flinders University, College of Medicine and Public Health, Sturt Rd, Bedford Park, SA 5042, Australia. Electronic address: .; Pokaż więcej
Źródło :: Addictive behaviors [Addict Behav] 2022 Jan; Vol. 124, pp. 107074. Date of Electronic Publication: 2021 Jul 30.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Homeless Persons*
Motivational Interviewing*
Smoking Cessation*
Adult ; Feasibility Studies ; Humans ; Male ; Pilot Projects ; Smoking ; Tobacco Use Cessation Devices ; Varenicline/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Recruiting racially and ethnically diverse smokers seeking treatment: Lessons learned from a smoking cessation randomized clinical trial.
Autorzy :: Asfar T; Department of Public Health Science, University of Miami Miller School of Medicine, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States. Electronic address: .
Koru-Sengul T; Department of Public Health Science, University of Miami Miller School of Medicine, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States.
Antoni MA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States.
Dorsey A; Department of Public Health Science, University of Miami Miller School of Medicine, United States.
Ruano Herreria EC; Department of Public Health Science, University of Miami Miller School of Medicine, United States.
Lee DJ; Department of Public Health Science, University of Miami Miller School of Medicine, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States.
Webb Hooper M; The National Institute on Minority Health and Health Disparities, United States.; Pokaż więcej
Źródło :: Addictive behaviors [Addict Behav] 2022 Jan; Vol. 124, pp. 107112. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :: Smoking Cessation*
African Americans ; Hispanic or Latino ; Humans ; Patient Selection ; Smokers
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Evaluating the feasibility and acceptability of a mobile-based health technology for smoking cessation: Mobile Anxiety Sensitivity Program.
Autorzy :: Garey L; Department of Psychology, University of Houston, Texas, USA.
Hébert ET; University of Texas Health Science Center (UTHealth) School of Public Health, Austin, Texas, USA.
Mayorga NA; Department of Psychology, University of Houston, Texas, USA.
Chavez J; Department of Psychology, University of Houston, Texas, USA.
Shepherd JM; Department of Psychology, University of Houston, Texas, USA.
Businelle MS; Oklahoma Tobacco Research Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Zvolensky MJ; Department of Psychology, University of Houston, Texas, USA.; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; HEALTH Institute, University of Houston, Texas, USA.; Pokaż więcej
Źródło :: The British journal of clinical psychology [Br J Clin Psychol] 2022 Jan; Vol. 61 Suppl 1, pp. 111-129. Date of Electronic Publication: 2021 May 03.
Typ publikacji :: Journal Article
MeSH Terms :: Mobile Applications*
Smoking Cessation*
Adult ; Anxiety/therapy ; Biomedical Technology ; Feasibility Studies ; Female ; Humans ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Pivoting the Provision of Smoking Cessation Education in a Virtual Clinical World: The Princess Margaret Cancer Centre Experience.
Autorzy :: Quartey NK; Cancer Education Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Papadakos J; Cancer Education Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.; Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada.; Patient Education, Ontario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Umakanthan B; Cancer Education Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.
Giuliani ME; Cancer Education Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2C4, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada.; Pokaż więcej
Źródło :: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Dec 15; Vol. 28 (6), pp. 5395-5400. Date of Electronic Publication: 2021 Dec 15.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*
Neoplasms*
Smoking Cessation*
Humans ; Pandemics ; SARS-CoV-2 ; Smoking
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: Smoking Cessation Rate and Its Predictors among Heavy Smokers in a Smoking-Free Hospital in Taiwan.
Autorzy :: Lin CJ; Department of Family Medicine, Mackay Memorial Hospital, Taipei 106, Taiwan.
Huang WH; Department of Family Medicine, Mackay Memorial Hospital, Taipei 106, Taiwan.; Community Health Center, Mackay Memorial Hospital, Taipei 106, Taiwan.; Division of Medicine, Mackay Medical College, New Taipei City 252, Taiwan.
Hsu CY; Department of Family Medicine, Mackay Memorial Hospital, Taipei 106, Taiwan.
Tjung JJ; Department of Family Medicine, Mackay Memorial Hospital, Taipei 106, Taiwan.
Chan HL; Department of Family Medicine, Mackay Memorial Hospital, Taipei 106, Taiwan.; Community Health Center, Mackay Memorial Hospital, Taipei 106, Taiwan.; Division of Medicine, Mackay Medical College, New Taipei City 252, Taiwan.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Dec 08; Vol. 18 (24). Date of Electronic Publication: 2021 Dec 08.
Typ publikacji :: Journal Article
MeSH Terms :: Smoking Cessation*
Hospitals ; Humans ; Middle Aged ; Smokers ; Smoking ; Taiwan/epidemiology ; Tobacco Use Cessation Devices ; Varenicline/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Daily use of nicotine replacement medications is related to daily smoking status: An ecological momentary assessment study.
Autorzy :: Hébert ET; University of Texas Health Science Center (UTHealth) School of Public Health, Austin, TX, United States. Electronic address: .
Bhushan T; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States.
Ra CK; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States.
Frank-Pearce S; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States.
Alexander AC; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Cole AB; Department of Psychology, Oklahoma State University, Stillwater, OK, United States.
Kendzor DE; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Businelle MS; TSET Health Promotion Research Center, Stephenson Cancer Center, Oklahoma City, OK, United States; Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.; Pokaż więcej
Źródło :: Drug and alcohol dependence [Drug Alcohol Depend] 2021 Dec 01; Vol. 229 (Pt A), pp. 109161. Date of Electronic Publication: 2021 Oct 29.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :: Smoking Cessation*
Administration, Cutaneous ; Ecological Momentary Assessment ; Female ; Humans ; Middle Aged ; Nicotine ; Smoking ; Smoking Prevention ; Tobacco Use Cessation Devices
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Varenicline administration for smoking cessation may reduce apnea hypopnea index in sleep apnea patients.
Autorzy :: Pataka A; Respiratory Failure Unit, G. Papanikolaou Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Frantzidis C; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Kalamaras G; Respiratory Failure Unit, G. Papanikolaou Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Gkivogkli P; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Kotoulas S; Respiratory Failure Unit, G. Papanikolaou Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Nday C; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Chriskos P; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Karagianni M; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Styliadis C; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .
Paraskevopoulos E; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Psychology, University of Cyprus, Nicosia, Cyprus. Electronic address: .
Kourtidou-Papadeli C; Greek Aerospace Medical Association and Space Research (GASMA-SR), Thessaloniki, Greece. Electronic address: .
Bamidis P; Lab of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .; Pokaż więcej
Źródło :: Sleep medicine [Sleep Med] 2021 Dec; Vol. 88, pp. 87-89. Date of Electronic Publication: 2021 Oct 13.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Sleep Apnea, Obstructive*
Smoking Cessation*
Female ; Humans ; Male ; Sleep Quality ; Sleep, REM ; Varenicline
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Association between educational level and smoking cessation in an 11-year follow-up study of a national health survey.
Autorzy :: Ruokolainen O; Finnish Institute for Health and Welfare, Finland.
Härkänen T; Finnish Institute for Health and Welfare, Finland.
Lahti J; Faculty of Social Sciences, University of Helsinki, Finland.
Haukkala A; Faculty of Social Sciences, University of Helsinki, Finland.; Helsinki Collegium for Advanced Studies, University of Helsinki, Finland.
Heliövaara M; Finnish Institute for Health and Welfare, Finland.
Rahkonen O; Department of Public Health, University of Helsinki, Finland.; Pokaż więcej
Źródło :: Scandinavian journal of public health [Scand J Public Health] 2021 Dec; Vol. 49 (8), pp. 951-960. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :: Journal Article
MeSH Terms :: Smoking Cessation*
Adult ; Aged ; Educational Status ; Female ; Follow-Up Studies ; Health Surveys ; Humans ; Male ; Smoking/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: European progress in working towards a tobacco-free generation.
Autorzy :: Been JV; Division of Neonatology, Department of Pediatrics, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, Netherlands. .; Department of Obstetrics and Gynaecology, Erasmus MC Sophia Children's Hospital, University Medical Centre Rotterdam, Rotterdam, Netherlands. .; Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands. .
Laverty AA; Public Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, UK.
Tsampi A; Department of Transboundary Legal Studies, Faculty of Law, University of Groningen, Groningen, Netherlands.
Filippidis FT; Public Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, UK.; Pokaż więcej
Źródło :: European journal of pediatrics [Eur J Pediatr] 2021 Dec; Vol. 180 (12), pp. 3423-3431. Date of Electronic Publication: 2021 May 25.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Smoking Cessation*
Tobacco Products*
Tobacco Smoke Pollution*
Adolescent ; Adult ; Child ; Humans ; Smoking Prevention ; Tobacco
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Establishment of a multimodal protocol combining a motivational interview, subcutaneous injection of NicoSan® and hyper-hydration for the "stopsmoking therapy": A multicentre real-life study'.
Autorzy :: Masetti V; Clinea Psychiatrie, 2, Rue Jean Jaurès, 92800 Puteaux, France. Electronic address: .
Hadj-Henni L; Clinique Pole de Santé du Plateau, 5-7, 9, Rue des Carnets, 92140 Clamart, France.
Rouger G; Clinique Castelviel-Pays d'Oc, Chemin des Affieux, Lieudit Castelviel, 31180 Castelmaurou, France.
Ben Bacha M; Clinique de l'Alliance, 3, Voie de l'Orchidée Sauvage, 93420 Villepinte, France.
Kechid L; Clinique de l'Alliance, 3, Voie de l'Orchidée Sauvage, 93420 Villepinte, France.; Pokaż więcej
Źródło :: L'Encephale [Encephale] 2021 Dec; Vol. 47 (6), pp. 518-532. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :: Clinical Trial Protocol; Journal Article
MeSH Terms :: Smoking Cessation*
Clinical Trials as Topic ; Humans ; Injections, Subcutaneous ; Multicenter Studies as Topic ; Plant Extracts ; Prospective Studies ; Smoking
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Exploring and reorienting psychiatrists' attitudes regarding smoking cessation and its potential to improve mental health outcomes: a pilot study.
Autorzy :: Short B; School of Medicine and Public Health, University of Newcastle, Gosford, NSW, Australia.; Central Coast Local Health District, Mental Health Service, Gosford, NSW, Australia.
Giles L; Central Coast Local Health District, Health Promotion Service, Gosford, NSW, Australia.
Karageorge A; Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
Bauer L; Health Promotion Service, Central Coast Local Health District, Gosford, NSW, Australia.; Pokaż więcej
Źródło :: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists [Australas Psychiatry] 2021 Dec; Vol. 29 (6), pp. 663-667. Date of Electronic Publication: 2021 Sep 06.
Typ publikacji :: Journal Article
MeSH Terms :: Psychiatry*
Smoking Cessation*
Attitude ; Australia ; Humans ; Mental Health ; Pilot Projects
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Smoking Cessation"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Smoking cessation.